Confluent Medical Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Confluent Medical Technologies is a US-based, private CDMO serving the medical device industry with a focus on materials science and complex manufacturing. Founded in 2015 through the rebranding of Nitinol Devices and Components (NDC), the company has grown via strategic acquisitions to offer a vertically integrated suite of capabilities from nitinol melting to finished device assembly. It operates eight global facilities with over 2,000 employees, positioning itself as a trusted partner for large-scale production of life-saving interventional and implantable devices. The company is backed by private equity firm TPG Capital and maintains a strong track record of innovation, as evidenced by recent product launches like Filmcast Select™ tubing.

CardiovascularNeurovascularStructural HeartPeripheral VascularGeneral Surgery

Technology Platform

Integrated CDMO platform specializing in advanced materials science for medical devices, including vertical integration in Nitinol (melting to finished components), proprietary Filmcast™ polymer tubing technology, complex catheter design/manufacturing, and implantable biomedical textiles.

Funding History

1

Private EquityUndisclosedGTCRJun 15, 2017

Opportunities

The global trend towards minimally invasive surgeries and the increasing outsourcing of complex manufacturing by medical device OEMs present a large and growing market.

Confluent's vertically integrated model in critical materials like nitinol and its proprietary polymer technologies position it to capture significant value as a preferred partner for next-generation device development and high-volume commercial production.

Risk Factors

Key risks include dependence on a concentrated customer base of large device OEMs, exposure to stringent regulatory quality requirements where any failure could be catastrophic, and competitive pressures in the CDMO landscape that could impact pricing and margins.

Competitive Landscape

Confluent competes with other large medical device CDMOs like Integer Holdings Corporation, Teleflex's OEM business, and Nordson MEDICAL, as well as smaller specialized firms. Its primary competitive advantages are deep, vertical integration in nitinol, a broad portfolio of complementary technologies (polymers, textiles, catheters), and a proven track record of scaling production for market-leading devices.

More companies in Drug Delivery & Formulation →More companies in United States →